Nuwellis, Inc. (NUWE) stock
NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.10−0.38 (-8.48%)
Close on Nov 17, 2026Market cap $2.36MP/E –Yield –
Nuwellis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nuwellis's revenue for the twelve months ending Jun 30, 2026 was $9.01M, up 8.4% year over year. For fiscal 2025 it was $8.27M, down 5.4% from the year before. Over ten years it grew 63.9% a year on average. The highest annual figure on record is $8.86M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.27M | -5.4% |
| FY2024 | Dec 31, 2024 | $8.74M | -1.4% |
| FY2023 | Dec 31, 2023 | $8.86M | +3.8% |
| FY2022 | Dec 31, 2022 | $8.54M | +7.9% |
| FY2021 | Dec 31, 2021 | $7.92M | +6.5% |
| FY2020 | Dec 31, 2020 | $7.44M | +35.0% |
| FY2019 | Dec 31, 2019 | $5.51M | +10.3% |
| FY2018 | Dec 31, 2018 | $5.00M | +40.7% |
| FY2017 | Dec 31, 2017 | $3.55M | +175.6% |
| FY2016 | Dec 31, 2016 | $1.29M | +2084.7% |
| FY2015 | Dec 31, 2015 | $59.00K | -80.0% |
| FY2014 | Dec 31, 2014 | $295.00K | +400.0% |
| FY2013 | Dec 31, 2013 | $59.00K | – |
| FY2012 | Dec 31, 2012 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.97M | +14.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.40M | +26.2% |
| Q4 FY2025 | Dec 31, 2025 | $2.42M | +4.4% |
| Q3 FY2025 | Sep 30, 2025 | $2.22M | -6.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.73M | -21.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.90M | +2.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.32M | -9.0% |
| Q3 FY2024 | Sep 30, 2024 | $2.37M | -1.9% |
| Q2 FY2024 | Jun 30, 2024 | $2.19M | +5.7% |
| Q1 FY2024 | Mar 31, 2024 | $1.86M | +1.7% |
| Q4 FY2023 | Dec 31, 2023 | $2.55M | +9.1% |
| Q3 FY2023 | Sep 30, 2023 | $2.41M | +16.8% |
| Q2 FY2023 | Jun 30, 2023 | $2.08M | -6.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.83M | -5.2% |
| Q4 FY2022 | Dec 31, 2022 | $2.34M | +42.4% |
| Q3 FY2022 | Sep 30, 2022 | $2.07M | +11.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.21M | -11.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.93M | +0.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.64M | -19.7% |
| Q3 FY2021 | Sep 30, 2021 | $1.85M | -2.7% |
| Q2 FY2021 | Jun 30, 2021 | $2.51M | +34.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.92M | +17.7% |
| Q4 FY2020 | Dec 31, 2020 | $2.04M | +49.5% |
| Q3 FY2020 | Sep 30, 2020 | $1.90M | +52.1% |
| Q2 FY2020 | Jun 30, 2020 | $1.86M | +11.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.63M | +34.2% |
| Q4 FY2019 | Dec 31, 2019 | $1.37M | -8.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.25M | -8.1% |
| Q2 FY2019 | Jun 30, 2019 | $1.68M | +52.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.22M | +17.2% |
| Q4 FY2018 | Dec 31, 2018 | $1.50M | +80.4% |
| Q3 FY2018 | Sep 30, 2018 | $1.36M | +42.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.10M | +27.2% |
| Q1 FY2018 | Mar 31, 2018 | $1.04M | +15.1% |
| Q4 FY2017 | Dec 31, 2017 | $831.00K | +11.4% |
| Q3 FY2017 | Sep 30, 2017 | $957.00K | +76.2% |
| Q2 FY2017 | Jun 30, 2017 | $864.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $901.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $746.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $543.00K | – |
See a number that looks wrong?